Focal, multifocal, or diffuse prostatic uptake. | Location of the primary tumor (right or left lobe or both) | Based on the record obtained from the nuclear medicine report. | Quantitative |
PET/CT studies, positive, negative. | Case numbers. | Based on the records obtained in the database. | Quantitative |
APE level. | A protein produced by the cells of the prostate glands, its concentration in the blood is measured. | The results were obtained from the files. | Quantitative |
Analysis based on the location of metastases. | Spread of prostate cancer to lymph nodes and organs. | Based on the PET/CT results, the anatomical location of the metastases was determined. | Quantitative |
Non-prostatic tumor uptakes. | Standardized value of uptake in lesions of non-prostate origin with 18F-PSMA | Based on the record obtained from the nuclear medicine report | Qualitative |
Focal uptakes in rib. | Standardized uptake value in ribs without anatomical representation. | Based on uptake rib focal only and determined predicter factors. | Qualitative |